S22-275 Composition and Method of Universal Programmable Virus-like Particles (VLPs) Stanford researchers have engineered retroviral and virus-like delivery systems for producing universal pseudotyped vehicles for cell and gene therapies. Lei Qi Michael Chavez Paul Finn
S20-259 Knock-In of Large DNA for Stable and Long-Term High Genomic Expression Advances in CRISPR-Cas technology have sparked a multitude of novel gene editing possibilities for therapeutic applications. Lei Qi Michael Chavez